JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002626200 on September 25, 2000

J. Biol. Chem., Vol. 275, Issue 50, 39671-39677, December 15, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/50/39671    most recent
M002626200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, D.
Right arrow Articles by Engelman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, D.
Right arrow Articles by Engelman, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Both the Structure and DNA Binding Function of the Barrier-to-Autointegration Factor Contribute to Reconstitution of HIV Type 1 Integration in Vitro*

Dylan Harris and Alan EngelmanDagger

From the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Retroviral integration is mediated by viral preintegration complexes (PICs), and human immunodeficiency virus type 1 (HIV-1) PICs treated with high salt lose their in vitro integration activity. Barrier-to-autointegration factor (BAF) is a host protein that efficiently restores PIC activity, but the mechanism(s) by which BAF participates in HIV-1 integration remains largely unknown. Here we developed a gel shift assay to study BAF DNA binding, and analyzed 14 mutant proteins containing substitutions of conserved residues for binding and PIC reconstitution activities. Although wild-type BAF efficiently bound double-stranded DNA, binding to single-stranded DNA, RNA, or an RNA/DNA hybrid was not detected, suggesting that BAF associates with retroviral cDNA relatively late during reverse transcription. Although some of the BAF mutant proteins efficiently bound DNA, others were defective for binding. Mutants that bound DNA efficiently reconstituted HIV-1 integration, even though in one case binding was just 0.2% of wild-type BAF. Although misfolded mutants did not reconstitute integration, a structurally intact DNA binding-defective mutant displayed partial activity at high BAF concentration. We therefore conclude that both BAF protein structure and its DNA binding activity play roles in reconstituting HIV-1 integration in vitro.


* This work was supported by National Institutes of Health Grant AI39394, by funds from the G. Harold and Lelia Y. Mathers Foundation, and by a gift from the Friends 10.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115. Tel.: 617-632-4361; Fax: 617-632-3113; E-mail: alan_engelman@dfci.harvard.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
M.-C. Shun, J. E. Daigle, N. Vandegraaff, and A. Engelman
Wild-Type Levels of Human Immunodeficiency Virus Type 1 Infectivity in the Absence of Cellular Emerin Protein
J. Virol., January 1, 2007; 81(1): 166 - 172.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. J. Nichols, M. S. Wiebe, and P. Traktman
The Vaccinia-related Kinases Phosphorylate the N' Terminus of BAF, Regulating Its Interaction with DNA and Its Retention in the Nucleus
Mol. Biol. Cell, May 1, 2006; 17(5): 2451 - 2464.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Turlure, G. Maertens, S. Rahman, P. Cherepanov, and A. Engelman
A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo
Nucleic Acids Res., March 20, 2006; 34(5): 1653 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Bengtsson and K. L. Wilson
Barrier-to-Autointegration Factor Phosphorylation on Ser-4 Regulates Emerin Binding to Lamin A In Vitro and Emerin Localization In Vivo
Mol. Biol. Cell, March 1, 2006; 17(3): 1154 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Chen, I. T. Weber, R. W. Harrison, and J. Leis
Identification of Amino Acids in HIV-1 and Avian Sarcoma Virus Integrase Subsites Required for Specific Recognition of the Long Terminal Repeat Ends
J. Biol. Chem., February 17, 2006; 281(7): 4173 - 4182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. de Oca, K. K. Lee, and K. L. Wilson
Binding of Barrier to Autointegration Factor (BAF) to Histone H3 and Selected Linker Histones Including H1.1
J. Biol. Chem., December 23, 2005; 280(51): 42252 - 42262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Oz Gleenberg, O. Avidan, Y. Goldgur, A. Herschhorn, and A. Hizi
Peptides Derived from the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 as Novel Inhibitors of the Viral Integrase
J. Biol. Chem., June 10, 2005; 280(23): 21987 - 21996.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mansharamani and K. L. Wilson
Direct Binding of Nuclear Membrane Protein MAN1 to Emerin in Vitro and Two Modes of Binding to Barrier-to-Autointegration Factor
J. Biol. Chem., April 8, 2005; 280(14): 13863 - 13870.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Mansharamani, D. R. M. Graham, D. Monie, K. K. Lee, J. E. K. Hildreth, R. F. Siliciano, and K. L. Wilson
Barrier-to-Autointegration Factor BAF Binds p55 Gag and Matrix and Is a Host Component of Human Immunodeficiency Virus Type 1 Virions
J. Virol., December 15, 2003; 77(24): 13084 - 13092.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Forne, M. Carrascal, L. Martinez-Lostao, J. Abian, J. L. Rodriguez-Sanchez, and C. Juarez
Identification of the Autoantigen HB as the Barrier-to-Autointegration Factor
J. Biol. Chem., December 12, 2003; 278(50): 50641 - 50644.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Priet, J.-M. Navarro, G. Querat, and J. Sire
Reversion of the Lethal Phenotype of an HIV-1 Integrase Mutant Virus by Overexpression of the Same Integrase Mutant Protein
J. Biol. Chem., May 30, 2003; 278(23): 20724 - 20730.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-W. Lin and A. Engelman
The Barrier-to-Autointegration Factor Is a Component of Functional Human Immunodeficiency Virus Type 1 Preintegration Complexes
J. Virol., April 15, 2003; 77(8): 5030 - 5036.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. Segura-Totten, A. K. Kowalski, R. Craigie, and K. L. Wilson
Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly
J. Cell Biol., August 5, 2002; 158(3): 475 - 485.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Serhan, N. Jourdan, S. Saleun, P. Moullier, and G. Duisit
Characterization of Producer Cell-Dependent Restriction of Murine Leukemia Virus Replication
J. Virol., June 5, 2002; 76(13): 6609 - 6617.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Dirks and A. D. Miller
Many Nonmammalian Cells Exhibit Postentry Blocks to Transduction by Gammaretroviruses Pseudotyped with Various Viral Envelopes, Including Vesicular Stomatitis Virus G Glycoprotein
J. Virol., July 15, 2001; 75(14): 6375 - 6383.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.